https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/activist-13d-13g-form-schedule-13g https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/amortization-of-deferred-loan-origination-fees-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/area-of-land https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/assets-held-for-sale-not-part-of-disposal-group https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/contract-with-customer-asset-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/contract-with-customer-refund-liability-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/conversion-of-stock-shares-converted https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-repaid https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-offering-costs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-asset-interest-carryforward https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/deferred-tax-liabilities-tax-deferred-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-asset https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-income-other https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/interest-receivable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/investment-income-amortization-of-discount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/long-term-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/long-term-notes-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/notes-assumed https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-impairment-loss https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-after-rolling-year-five https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/participating-securities-distributed-and-undistributed-earnings-loss-basic https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-for-deposits https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-repurchase-of-equity https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/revenue-not-from-contract-with-customer https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-comment-letters-drsltr https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-drs https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/short-term-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/supplies https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-dividends-adjustment https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/total-contract-liability https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/treasury-stock-value https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/marinus-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted